Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | RXRA | P19793 | 5/20 | 0.31 |
| ▸ | GRIN1 | Q05586 | 5/20 | 0.31 |
| ▸ | GRIN2B | Q13224 | 5/20 | 0.31 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28944777 | 0.84 | — | — | |
| SCHEMBL12924638 | 0.81 | LMNA (0.36) | MEN1KMT2A | |
| SCHEMBL17395038 | 0.76 | ACACB (0.30) | — | |
| SCHEMBL15933172 | 0.76 | RXRA (0.35) | KDM4ERXRAGRIN1GRIN2BHDAC4 | |
| SCHEMBL8354332 | 0.73 | FGFR4 (0.38) | MEN1KMT2AKDM4E | |
| SCHEMBL22519659 | 0.72 | KDM4E (0.41) | MEN1KMT2AKDM4ERXRAGRIN1 | |
| SCHEMBL22428387 | 0.72 | RXRA (0.33) | KDM4ERXRAGRIN1GRIN2BHDAC4 | |
| SCHEMBL3965140 | 0.72 | F2RL3 (0.32) | RXRAGRIN1GRIN2B | |
| SCHEMBL21275802 | 0.71 | ROCK1 (0.41) | MEN1KMT2AKDM4ERXRAGRIN1 | |
| SCHEMBL355741 | 0.71 | RXRA (0.39) | MEN1KMT2AKDM4ERXRAGRIN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118561817-A | Novel heteroaryl-triazole compounds as pesticides | 拜耳公司 | 2024-08-30 | — | — | CN | disclosed |
| CN-118496198-A | Novel heteroaryl-triazole compounds as pesticides | 拜耳公司 | 2024-08-16 | — | — | CN | disclosed |
| CN-114502545-B | Novel heteroaryl-triazole compounds as pesticides | 拜耳公司 | 2024-06-28 | — | — | CN | disclosed |
| CN-112204021-B | Novel heteroaryl triazoles and heteroaryl tetrazoles as pesticides | 拜耳公司 | 2024-05-28 | — | — | CN | disclosed |
| CN-114502545-A | Novel heteroaryl-triazole compounds as pesticides | 拜耳公司 | 2022-05-13 | — | — | CN | disclosed |
| CN-114423748-A | Novel heteroaryl triazole compounds as pesticides | 拜耳公司 | 2022-04-29 | — | — | CN | disclosed |
| CN-112204021-A | Novel heteroaryltriazole and heteroaryltetrazole compounds as pesticides | 拜耳公司 | 2021-01-08 | — | — | CN | disclosed |
| WO-2016001266-A1 | FLUORO-[1,3]OXAZINES AS BACE1 INHIBITORS | F. HOFFMANN-LA ROCHE AG (CH) | 2016-01-07 | — | — | WO | disclosed |
| US-20130131074-A1 | PYRIDONE AND PYRIDAZONE ANALOGUES AS GPR119 MODULATORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2013-05-23 | — | — | US | disclosed |
| US-8372837-B2 | Pyridone and pyridazone analogues as GPR119 modulators | BRISTOL-MYERS SQUIBB COMPANY (US) | 2013-02-12 | — | — | US | disclosed |
| EP-2313395-B1 | PYRIDONE AND PYRIDAZONE ANALOGUES AS GPR119 MODULATORS | BRISTOL MYERS SQUIBB CO (US) | 2012-12-19 | — | — | EP | disclosed |
| US-20110263548-A1 | PYRIDONE AND PYRIDAZONE ANALOGUES AS GPR119 MODULATORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2011-10-27 | — | — | US | disclosed |
| EP-2313395-A1 | PYRIDONE AND PYRIDAZONE ANALOGUES AS GPR119 MODULATORS | Bristol-Myers Squibb Company (US) | 2011-04-27 | — | — | EP | disclosed |
| WO-2010009183-A1 | PYRIDONE AND PYRIDAZONE ANALOGUES AS GPR119 MODULATORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2010-01-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130131074-A1 | PYRIDONE AND PYRIDAZONE ANALOGUES AS GPR119 MODULATORS | GPR119, GPR4, GPR3 | MEN1 2531/4885KMT2A 3211/4885KDM4E 3227/4885 |
| US-20110263548-A1 | PYRIDONE AND PYRIDAZONE ANALOGUES AS GPR119 MODULATORS | GPR119, GPR4, GPR3 | MEN1 2449/4885KMT2A 3266/4885KDM4E 3226/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.